Amexdrug Corporation (AXRX)

Market Cap	33.82K -99.8%
Revenue (ttm)	9.17M -12.2%
Net Income	165.83K +1,354.6%
EPS	0.00 +1,359.7%
Shares Out	169.11M
PE Ratio	0.20
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,000
Average Volume	3,046
Open	0.0002
Previous Close	n/a
Day's Range	0.0002 - 0.0002
52-Week Range	0.0001 - 0.0002
Beta	-0.52
RSI	32.66
Earnings Date	n/a

About Amexdrug

Amexdrug Corporation, through its subsidiaries, engages in the research, development, manufacturing, and distribution of pharmaceutical drugs in the United States. The company operates in two segments, Distribution, and Health and Beauty Products. It offers brand and generic pharmaceuticals, prescription and over-the-counter drugs, non-drug products, health and beauty products, nutritional supplements, as well as pharmacy and laboratory supplies under the Sponix brand name. The company is also involved in private manufacturing and labeling acti...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1963
• Employees: 13
• Stock Exchange: OTCMKTS
• Ticker Symbol: AXRX

Financial Performance

In 2012, Amexdrug's revenue was $9.15 million, a decrease of -26.26% compared to the previous year's $12.41 million. Earnings were $82,034, a decrease of -18.49%.